<DOC>
	<DOCNO>NCT01950039</DOCNO>
	<brief_summary>Betaine important cellular metabolic pathway . Few epidemiologic study link betaine level diabetes cardiovascular disease . Small human study suggest benefit non-alcoholic liver disease . In study determine administration betaine improve metabolic measure , liver fat and/or endothelial function human glucose intolerance overweight .</brief_summary>
	<brief_title>Metabolic Effects Betaine Supplementation</brief_title>
	<detailed_description>This study single site , prospective , randomize ( 1:1 ) , double mask , placebo control trial ass metabolic effect betaine compare placebo glycemia insulin sensitivity , liver fat endothelial function .</detailed_description>
	<mesh_term>Betaine</mesh_term>
	<criteria>1 ) Men woman age 2165 year old ; 2 ) Dysglycemia/prediabetes define impaired fasting glucose ( ≥100 mg/dl ) , impair glucose tolerance ( 2 hour post 75 g oral glucose load 140200 mg/dl ) HbA1c 5.76.5 % ) ; 3 ) Grade 1 obesity ( BMI 27 36 kg/m2 ) . 1 ) cystathionine betasynthase ( CBS deficiency ) ; 2 ) Presence liver disease NAFLD ; 3 ) Use medication cause steatosis ; 4 ) Known alcohol consumption ≥ 2 drink per day ; 5 ) Use medication know cause insulin resistance ; 6 ) Use weight loss drug ( program ) within 3 month screen ; 7 ) Treatment experimental drug within past 6 month ; 8 ) Subjects must willing abstain use phosphodiesterase type 5 ( PDE5 ) inhibitor ; 9 ) Pregnancy lactation , woman child bear potential must use adequate contraception ; 10 ) Surgery within 30 day screen ; 11 ) Heart disease define New York Heart Association Class III IV cardiac status hospitalization congestive heart failure , unstable angina , myocardial infarction , cerebrovascular accident , transient ischemic attack revascularization within 6 month ; 12 ) Uncontrolled hypertension ; 13 ) eGFR &lt; 60 ; 14 ) History acquire immune deficiency syndrome ; 15 ) History malignancy within 5 year ; 16 ) Hemoglobin &lt; 12 g/dL ( male ) , &lt; 10 g/dL ( female ) ; 17 ) Triglycerides ( TG ) &gt; 500 mg/dL ; 18 ) Poor mental function reason expect patient difficulty comply study requirement ; 19 ) Metal clip implant preclude magnetic resonance imaging .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Obesity</keyword>
	<keyword>Glucose Intolerance</keyword>
</DOC>